HP
Hikari Power Portfolio holdings
AUM
$1.2B
This Quarter Return
+7.24%
1 Year Return
+14.18%
3 Year Return
+56.59%
5 Year Return
+122.08%
10 Year Return
+191.59%
AUM
$984M
AUM Growth
+$984M
(+8.3%)
Cap. Flow
+$13.1M
Cap. Flow
% of AUM
1.34%
Top 10 Holdings %
Top 10 Hldgs %
54.55%
Holding
135
New
7
Increased
20
Reduced
9
Closed
8
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
$7.02M |
| 2 |
General Mills
GIS
|
$4.27M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
$3.52M |
| 4 |
Johnson & Johnson
JNJ
|
$3.4M |
| 5 |
Kraft Heinz
KHC
|
$2.8M |
Top Sells
| 1 |
IBM
IBM
|
$12.3M |
| 2 |
Amgen
AMGN
|
$2.9M |
| 3 |
Gilead Sciences
GILD
|
$2.69M |
| 4 |
Biogen
BIIB
|
$2.01M |
| 5 |
CELG
Celgene Corp
CELG
|
$1.63M |
Sector Composition
| 1 | Financials | 35.78% |
| 2 | Healthcare | 22.27% |
| 3 | Industrials | 11.22% |
| 4 | Technology | 7.01% |
| 5 | Consumer Staples | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Berkshire Hathaway Class A
BRK.A
$1.09T
| $232M | 23.59% | 725 +11 | +2% | +$3.52M |
|
2
Wells Fargo
WFC
$263B
| $81.2M | 8.25% | 1,544,420 | – | – |
|
|
3
Johnson & Johnson
JNJ
$427B
| $37.5M | 3.81% | 271,510 +24,590 | +10% | +$3.4M |
|
4
3M
MMM
$82.8B
| $31.5M | 3.21% | 149,660 +7,450 | +5% | +$1.57M |
|
|
AGN
5
DELISTED
Allergan plc
AGN
| $29.3M | 2.97% | 153,580 +36,850 | +32% | +$7.02M |
|
6
Phillips 66
PSX
$54B
| $27.7M | 2.81% | 245,470 | – | – |
|
7
Visa
V
$683B
| $25.8M | 2.62% | 171,900 | – | – |
|
|
PX
8
DELISTED
Praxair Inc
PX
| $24.3M | 2.47% | 151,020 | – | – |
|
9
Boeing
BA
$177B
| $23.9M | 2.43% | 64,300 | – | – |
|
10
Danaher
DHR
$147B
| $23.4M | 2.38% | 215,800 | – | – |
|
11
RTX Corp
RTX
$212B
| $22.8M | 2.32% | 163,350 -2,300 | -1% | -$322K |
|
|
12
IBM
IBM
$227B
| $21.9M | 2.23% | 144,990 -81,600 | -36% | -$12.3M |
|
13
Nutrien
NTR
$28B
| $21.7M | 2.21% | 376,360 | – | – |
|
14
Roper Technologies
ROP
$56.6B
| $21M | 2.14% | 71,020 | – | – |
|
15
Wabtec
WAB
$33.1B
| $20.2M | 2.06% | 192,770 | – | – |
|
16
DaVita
DVA
$9.85B
| $19.3M | 1.97% | 269,940 | – | – |
|
17
Novo Nordisk
NVO
$251B
| $16M | 1.62% | 339,040 | – | – |
|
18
Procter & Gamble
PG
$368B
| $14.5M | 1.47% | 174,200 | – | – |
|
|
19
Kraft Heinz
KHC
$33.1B
| $14M | 1.42% | 254,130 +50,870 | +25% | +$2.8M |
|
20
Fortive
FTV
$16.2B
| $11.9M | 1.21% | 141,700 | – | – |
|
|
21
General Mills
GIS
$26.4B
| $11.6M | 1.18% | 270,600 +99,600 | +58% | +$4.27M |
|
22
Exxon Mobil
XOM
$487B
| $11.1M | 1.13% | 130,393 | – | – |
|
23
Intuitive Surgical
ISRG
$170B
| $10.7M | 1.09% | 18,650 | – | – |
|
|
ESRX
24
DELISTED
Express Scripts Holding Company
ESRX
| $10.6M | 1.08% | 111,740 | – | – |
|
25
Waters Corp
WAT
$18B
| $10.1M | 1.03% | 51,800 | – | – |
|